SCHEDULE OF CASH AND CASH EQUIVALENTS AND INVESTMENTS (Details) - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Impairment Effects on Earnings Per Share [Line Items]
Cash and Cash Equivalents	$ 1,848,295	$ 5,619,083
Cash [Member]
Impairment Effects on Earnings Per Share [Line Items]
Cost	109,659	242,271
Unrealized Gain (Loss)
Fair Value
Cash and Cash Equivalents	109,659	242,271
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Cost	1,738,636	5,376,812
Unrealized Gain (Loss)
Fair Value	1,738,636	5,376,812
Cash and Cash Equivalents	1,738,636	5,376,812
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Cost	1,848,295	5,619,083
Unrealized Gain (Loss)
Fair Value	1,738,636	5,376,812
Cash and Cash Equivalents	$ 1,848,295	$ 5,619,083